Journal of International Oncology ›› 2025, Vol. 52 ›› Issue (6): 353-359.doi: 10.3760/cma.j.cn371439-20241009-00060
• Original Article • Previous Articles Next Articles
Hao Chunhai
Received:
2024-10-09
Revised:
2024-11-19
Online:
2025-06-08
Published:
2025-06-26
Hao Chunhai. Efficacy of rapamycin arterial perfusion combined with 131I-FAP loaded dextran microspheres for interventional embolization in the treatment of rabbits with liver transplantation tumor[J]. Journal of International Oncology, 2025, 52(6): 353-359.
"
组别 | 肿瘤质量(g) | 肿瘤体积(cm3) | 肿瘤坏死率(%) | 抑瘤率(%) |
---|---|---|---|---|
MO组 | 20.33±2.39 | 0.87±0.13 | 21.11±2.14 | 0.00±0.00 |
RA组 | 14.62±1.23a | 0.51±0.09a | 32.18±3.25a | 24.66±2.47a |
IF组 | 14.34±1.22a | 0.53±0.08a | 32.29±3.28a | 24.13±2.46a |
RI组 | 8.28±0.84abc | 0.32±0.02abc | 48.53±4.37abc | 45.55±4.51abc |
F值 | 316.40 | 159.50 | 356.10 | 571.30 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
"
组别 | ALB(g/L) | ALT(U/L) | AST(U/L) | TBIL(μmoL/L) |
---|---|---|---|---|
NO组 | 40.55±4.38 | 19.68±1.34 | 74.27±7.48 | 22.42±2.58 |
MO组 | 17.34±1.02a | 92.17±9.24a | 182.21±20.23a | 82.24±8.35a |
RA组 | 22.65±2.18ab | 78.71±7.39ab | 165.78±16.05ab | 61.86±6.17ab |
IF组 | 22.37±2.17ab | 78.35±7.40ab | 165.26±16.09ab | 61.53±6.16ab |
RI组 | 29.01±2.83abcd | 50.30±5.12abcd | 102.33±11.11abcd | 46.45±4.53abcd |
F值 | 105.90 | 189.00 | 99.57 | 142.10 |
P值 | <0.001 | <0.001 | <0.001 | <0.001 |
[1] | Li F, Liu P, Mi W, et al. Blocking methionine catabolism induces senescence and confers vulnerability to GSK3 inhibition in liver cancer[J]. Nat Cancer, 2024, 5(1): 131-146. DOI: 10.1038/s43018-023-00671-3. |
[2] | Lv H, Zong Q, Chen C, et al. TET2-mediated tumor cGAS triggers endothelial sting activation to regulate vasculature remodeling and anti-tumor immunity in liver cancer[J]. Nat Commun, 2024, 15(1): 6. DOI: 10.1038/s41467-023-43743-9. |
[3] |
Yang H, Cheng J, Zhuang H, et al. Pharmacogenomic profiling of intra-tumor heterogeneity using a large organoid biobank of liver cancer[J]. Cancer Cell, 2024, 42(4): 535-551.e8. DOI: 10.1016/j.ccell.2024.03.004.
pmid: 38593780 |
[4] | Xue Y, Ruan Y, Wang Y, et al. Signaling pathways in liver cancer: pathogenesis and targeted therapy[J]. Mol Biomed, 2024, 5(1): 20. DOI: 10.1186/s43556-024-00184-0. |
[5] | Zhang Z, Shen C, Zhou F. Correction to: the natural medicinal fungus huaier promotes the anti-hepatoma efficacy of sorafenib through the mammalian target of rapamycin-mediated autophagic cell death[J]. Med Oncol, 2023, 40(2): 83. DOI: 10.1007/s12032-022-01920-8. |
[6] | 朱鸷翔, 沈松鹤, 赵森, 等. 腹主动脉灌注雷帕霉素联合肝动脉化疗治疗肝移植瘤兔模型疗效分析[J]. 现代肿瘤医学, 2020, 28(23): 4032-4036. DOI: 10.3969/j.issn.1672-4992.2020.23.003. |
[7] | Wu X, Ge L, Shen G, et al. 131I-labeled silk fibroin microspheres for radioembolic therapy of rat hepatocellular carcinoma[J]. ACS Appl Mater Interfaces, 2022, 14(19): 21848-21859. DOI: 10.1021/acsami.2c00211. |
[8] | Liu X, Li D, Ma T, et al. Autophagy inhibition improves the targeted radionuclide therapy efficacy of 131I-FAP-2286 in pancreatic cancer xenografts[J]. J Transl Med, 2024, 22(1): 156. DOI: 10.1186/s12967-024-04958-6. |
[9] | 谷铁树, 李博, 吴勇超, 等. 碘油与葡聚糖微球栓塞兔肝VX2移植瘤疗效对比[J]. 河北医科大学学报, 2020, 41(9): 1089-1093. DOI: 10.3969/j.issn.1007-3205.2020.09.022. |
[10] | Prasad YR, Anakha J, Pande AH. Treating liver cancer through arginine depletion[J]. Drug Discov Today, 2024, 29(4): 103940. DOI: 10.1016/j.drudis.2024.103940. |
[11] | Tong Y, Wang F, Li S, et al. Histone methyltransferase KMT5C drives liver cancer progression and directs therapeutic response to PARP inhibitors[J]. Hepatology, 2024, 80(1): 38-54. DOI: 10.1097/HEP.0000000000000559. |
[12] | Wang Y, Lin W, Huang G, et al. The therapeutic principle of combined clearing heat and resolving toxin plus TACE on primary liver cancer: a systematic review and meta-analysis[J]. J Ethnopharmacol, 2024, 319(Pt 1): 117072. DOI: 10.1016/j.jep.2023.117072. |
[13] | Ma H, Li F, Shen G, et al. Synthesis and preliminary evaluation of 131I-labeled FAPI tracers for cancer theranostics[J]. Mol Pharm, 2021, 18(11): 4179-4187. DOI: 10.1021/acs.molpharmaceut.1c00566. |
[14] |
Ardjmand D, Kubota Y, Sato M, et al. Selective synergy of rapamycin combined with methioninase on cancer cells compared to normal cells[J]. Anticancer Res, 2024, 44(3): 929-933. DOI: 10.21873/anticanres.16887.
pmid: 38423628 |
[15] | 童倩倩. 负载-(131)I-FAP的葡聚糖微球的构建并用于兔VX2肝移植瘤介入栓塞治疗的初步研究[D]. 宜春: 宜春学院, 2023. DOI: 10.27928/d.cnki.gycxy.2023.000014. |
[16] |
Chen M, Liu W, Liu B. Cryoablation with KCl solution enhances necrosis and apoptosis of HepG2 liver cancer cells[J]. Ann Biomed Eng, 2024, 52(8): 2118-2133. DOI: 10.1007/s10439-024-03512-1.
pmid: 38615077 |
[17] |
Shi Z, Hu M, Bian J. 99mTc-HYNIC-annexin V detection of apoptosis in the rabbit model of liver cancer[J]. Cell Mol Biol (Noisy-le-grand), 2024, 70(7): 143-147. DOI: 10.14715/cmb/2024.70.7.20.
pmid: 39097883 |
[18] | 孙潺, 张轩斌, 赵江, 等. 雷帕霉素对肺癌SPC-A-1细胞增殖和凋亡的影响[J]. 临床肺科杂志, 2023, 28(6): 829-833. DOI: 10.3969/j.issn.1009-6663.2023.06.004. |
[19] | Wu T, Yao Y, Sun R, et al. Arterial instillation of rapamycin in treatment of rabbit hepatic xenograft tumors and its effects on VEGF, iNOS, HIF-1α, Bcl-2, Bax expression and microvessel density[J]. Sci Prog, 2021, 104(3): 368504211026417. DOI: 10.1177/00368504211026417. |
[20] | You M, Fu J, Lv X, et al. Saikosaponin b2 inhibits tumor angioge-nesis in liver cancer via down-regulation of VEGF/ERK/HIF-1α signaling[J]. Oncol Rep, 2023, 50(1): 136. DOI: 10.3892/or.2023.8573. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||